Point72 Middle East FZE »

Emergent BioSolutions shares owned by Point72 Middle East FZE

Quarter-by-quarter ownership of Emergent BioSolutions (EBS) shares owned by Point72 Middle East FZE from 13F filings

Historical chart of Point72 Middle East FZE investment in Emergent BioSolutions

Tip: Access up to 7 years of quarterly data

All positions including Emergent BioSolutions held by Point72 Middle East FZE consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Emergent BioSolutions by Point72 Middle East FZE

Quarter filed Position value Share count Share price at filing
2023-12-31 $195k 81k 2.40
2023-09-30 $721k 212k 3.40
2023-03-31 $376k 36k 10.36

More positions owned by Point72 Middle East FZE

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Spdr Dow Jones Indl Average Ut Ser 1 Call Option (DIA)
General Motors Company (GM)
Eli Lilly & Co. (LLY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Caterpillar Call Option (CAT)
UnitedHealth (UNH)
Amazon (AMZN)
Jd.com Spon Adr Cl A (JD)
Lauder Estee Cos Cl A Call Option (EL)
Target Corporation Call Option (TGT)
At&t (T)
Analog Devices Call Option (ADI)
Synopsys (SNPS)

View all positions for Point72 Middle East FZE

Top funds holding Emergent BioSolutions

Vanguard Group
Charles Schwab Investment Management
Millennium Management
Hotchkis and Wiley Capital Management
D. E. Shaw & Co
Two Sigma Advisers
Jacobs Levy Equity Management
Two Sigma Investments
Prescott Group Capital Management
Assenagon Asset Management
Goldman Sachs Group
Dimensional Fund Advisors
AQR Capital Management
Cubist Systematic Strategies
Values First Advisors

View all funds holding Emergent BioSolutions